Propanc Biopharma, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Sep 2011 | $-39.0K | $-39.0K | — | — |
| Dec 2011 | $-1.2K | $-1.2K | — | — |
| Mar 2012 | $-74.2K | $-74.2K | — | — |
| Jun 2012 | $-56.0K | $-56.0K | — | — |
| Sep 2012 | $-72.0K | $-72.0K | — | — |
| Dec 2012 | $-5.9K | $-5.9K | — | — |
| Mar 2013 | $-18.8K | $-18.8K | — | — |
| Jun 2013 | $-31.9K | $-31.9K | — | — |
| Sep 2013 | $-75.2K | $-75.2K | — | — |
| Dec 2013 | $-26.6K | $-26.6K | — | — |
| Mar 2014 | $-35.8K | $-35.8K | — | — |
| Jun 2014 | $364.1K | $364.1K | — | — |
| Sep 2014 | $99.8K | $99.8K | $0 | — |
| Dec 2014 | $172.2K | $172.2K | $0 | — |
| Mar 2015 | $-969.5K | $-970.5K | $918 | — |
| Jun 2015 | $-728.9K | $-731.9K | $3.0K | — |
| Sep 2015 | $-405.7K | $-406.4K | $679 | — |
| Dec 2015 | $-1.1M | $-1.1M | $-3 | — |
| Mar 2016 | $-716.9K | $-716.9K | $0 | — |
| Jun 2016 | $-2.3M | $-2.3M | $9.2K | — |
| Sep 2016 | $-683.6K | $-683.6K | $0 | — |
| Dec 2016 | $-321.0K | $-321.0K | $0 | — |
| Mar 2017 | $-444.5K | $-444.5K | — | — |
| Jun 2017 | $-601.6K | $-601.6K | — | — |
| Sep 2017 | $-785.7K | $-785.7K | — | $164.9K |
| Dec 2017 | $-285.7K | $-285.7K | — | $164.9K |
| Mar 2018 | $-658.8K | $-658.8K | — | $161.3K |
| Jun 2018 | $-447.6K | $-447.6K | — | $25.1K |
| Sep 2018 | $-419.2K | $-419.2K | — | — |
| Dec 2018 | $-637.6K | $-637.6K | — | — |
| Mar 2019 | $-737.0K | $-737.0K | — | — |
| Jun 2019 | $-266.2K | $-266.2K | — | — |
| Sep 2019 | $-726.3K | $-726.3K | — | $114.9K |
| Dec 2019 | $-416.5K | $-416.5K | — | $20.7K |
| Mar 2020 | $-207.1K | $-207.1K | — | $20.7K |
| Jun 2020 | $-499.7K | $-499.7K | — | $144.1K |
| Sep 2020 | $-179.9K | $-179.9K | — | $20.7K |
| Dec 2020 | $-261.0K | $-261.0K | — | $20.7K |
| Mar 2021 | $-468.0K | $-468.0K | — | $20.7K |
| Jun 2021 | $-236.3K | $-236.3K | — | $20.7K |
| Sep 2021 | $-486.8K | $-486.8K | — | $20.7K |
| Dec 2021 | $-224.3K | $-224.3K | — | $20.7K |
| Mar 2022 | $-314.2K | $-314.2K | — | $20.7K |
| Jun 2022 | $-411.0K | $-411.0K | — | $10.4K |
| Sep 2022 | $-509.3K | $-509.3K | — | $2.4K |
| Dec 2022 | $-225.2K | $-225.2K | — | $0 |
| Mar 2023 | $-192.7K | $-192.7K | — | $0 |
| Jun 2023 | $-178.0K | $-178.0K | — | $0 |
| Sep 2023 | $-333.5K | $-333.5K | — | — |
| Dec 2023 | $-238.9K | $-238.9K | — | — |
| Mar 2024 | $-102.8K | $-102.8K | — | — |
| Jun 2024 | $-260.0K | $-260.0K | — | — |
| Sep 2024 | $-235.5K | $-235.5K | — | — |
| Dec 2024 | $18.7K | $18.7K | — | — |
| Mar 2025 | $-96.2K | $-96.2K | — | — |
| Jun 2025 | $-92.2K | $-92.2K | — | — |
| Sep 2025 | $-1.9M | $-1.9M | $2.5K | $3.0M |
| Dec 2025 | $-999.1K | $-1.0M | $2.3K | $2.5M |
| Mar 2026 | $-1.1M | $-1.1M | $154 | $1.8M |
| Jun 2026 | $-1.6M | $-1.6M | $21 | $1.2M |